Crescent Capital BDC (CCAP) Set to Announce Quarterly Earnings on Monday

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) will be announcing its earnings results after the market closes on Monday, November 11th. Analysts expect the company to announce earnings of $0.57 per share for the quarter. Parties interested in listening to the company’s conference call can do so using this link.

Crescent Capital BDC (NASDAQ:CCAPGet Free Report) last posted its quarterly earnings results on Monday, August 12th. The company reported $0.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.58 by $0.01. The business had revenue of $48.95 million during the quarter, compared to analyst estimates of $48.05 million. Crescent Capital BDC had a net margin of 51.61% and a return on equity of 12.03%. During the same period in the prior year, the business posted $0.56 earnings per share. On average, analysts expect Crescent Capital BDC to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Crescent Capital BDC Stock Down 0.9 %

CCAP opened at $18.02 on Monday. Crescent Capital BDC has a 12 month low of $15.91 and a 12 month high of $19.63. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 1.17. The business’s 50-day moving average price is $18.42 and its 200-day moving average price is $18.36. The company has a market cap of $667.82 million, a P/E ratio of 6.55 and a beta of 0.81.

Crescent Capital BDC Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, October 15th. Shareholders of record on Monday, September 30th were paid a $0.42 dividend. This is a boost from Crescent Capital BDC’s previous quarterly dividend of $0.09. This represents a $1.68 dividend on an annualized basis and a yield of 9.32%. The ex-dividend date was Monday, September 30th. Crescent Capital BDC’s payout ratio is 61.09%.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on the stock. Wells Fargo & Company cut their target price on shares of Crescent Capital BDC from $19.00 to $18.00 and set an “equal weight” rating on the stock in a report on Wednesday, August 14th. LADENBURG THALM/SH SH started coverage on shares of Crescent Capital BDC in a report on Monday, September 30th. They issued a “buy” rating and a $20.00 price target on the stock. Finally, Bank of America lowered their price objective on shares of Crescent Capital BDC from $20.00 to $19.00 and set a “buy” rating for the company in a research note on Thursday, August 15th. One investment analyst has rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $19.00.

Read Our Latest Analysis on Crescent Capital BDC

About Crescent Capital BDC

(Get Free Report)

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.

Further Reading

Earnings History for Crescent Capital BDC (NASDAQ:CCAP)

Receive News & Ratings for Crescent Capital BDC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crescent Capital BDC and related companies with MarketBeat.com's FREE daily email newsletter.